期刊文献+

乙肝合并NAFLD患者肝功能及病毒复制与脂代谢水平相关性分析 被引量:2

Correlation of Liver Function and Viral Replication with Lipid Metabolism in Patients with Hepatitis B and NAFLD
下载PDF
导出
摘要 目的研究乙肝合并NAFLD患者肝功能及病毒复制与脂代谢水平相关性.方法选择乙型肝炎患者138例,分为有患者分为慢性乙型肝炎组(A组)及慢性乙型肝炎合并NAFLD组(B组),分别有65例、73例,同时选择50名健康人群作为对照组(C组).分别检测肝功能肝功能、HBV-DNA及血清脂肪因子水平.结果A组较C组ALT及AST差异有统计学意义(P<0.05),B组较A组及C组ALT及AST差异有统计学意义(P<0.05).A组较C组Chemerin、内脂素、瘦素水平差异有统计学意义(P<0.05),B组较A组及C组Chemerin、内脂素、瘦素水平均差异有统计学意义(P<0.05).Chemerin及瘦素与ALT、AST呈正相关(P<0.05),内脂素与AST呈正相关(P<0.05).结论乙肝合并NAFLD患者肝功能与脂代谢紊乱具有较好的相关性,两者共同参与了NAFLD的形成. Objective To investigate the correlation of liver function and viral replication with lipid metabolism in patients with hepatitis B and NAFLD.Methods One hundred and thirty-eight cases of hepatitis B patients were divided into chronic hepatitis B group (group A,65 cases) and chronic hepatitis B with NAFLD group (group B,73 cases),while 50 healthy people were selected as a control group (group C).Liver function,HBV-DNA and serum adipokine levels were detected.Results ALT,AST,chemerin,visfatin,and leptin levels in group A were significantly increased compared with group C (P<0.05),and in group B were significantly increased compared with groups A and C (P<0.05).Chemerin and leptin showed significant positive correlations with ALT and AST (P<0.05),and visfatin showed significant positive correlation with AST (P<0.05).Conclusion Liver function in patients with NAFLD has a good correlation with dyslipidemia,which participate in the formation of NAFLD.
作者 杨静 黄崇亚
出处 《昆明医科大学学报》 CAS 2014年第5期111-113,共3页 Journal of Kunming Medical University
基金 陕西省科技攻关基金资助项目(2007k15-05)
关键词 乙肝 NAFLD 肝功能 脂代谢 Hepatitis B NAFLD Liver function Lipid metabolism
  • 相关文献

参考文献2

二级参考文献18

  • 1张文胜,王宝恩,王泰龄,欧晓娟,陈煜,李琴,王小明,钱林学,马红,贾继东.慢性乙型肝炎肝纤维化无创性诊断模型的建立[J].中华肝脏病杂志,2006,14(3):169-173. 被引量:81
  • 2杨宏志,孙琰碧.血瘀分型辨治乙肝后肝纤维化患者血清透明质酸[J].陕西中医学院学报,1996,19(2):41-42. 被引量:7
  • 3肝纤维化中西医结合诊疗指南[J].中西医结合肝病杂志,2006,16(5):316-320. 被引量:168
  • 4Fattovich G. Natural history and prognosis of hepa- titis B[J]. Semin Liver Dis, 2003,23(1 ):47-58.
  • 5McMahon BJ. The natural history of chronic hepa- titis B virus infection[J]. Semin Liver Dis, 2004, 24(1) : 17 -21.
  • 6Hadziyannis S J, Papatheodoridis GV. Hepatitis be antigen negative chronic hepatitis B-natural histo- ry and treatment[J]. Semin Liver Dis, 2006, 26 (2): 130-141.
  • 7Fattovich G, Bortolotti F, Donato F. Natural histo- ry of chronic hepatitis B. special emphasis on disease progression and prognostic factors[J ]. Hepatology, 2008, 48(2): 335 -352.
  • 8Fattovich G, Olivari N, Pasino M, et al. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years[J]. Gut, 2008, 57(1): 84 -90.
  • 9Fattovich G, Stroffolini T, Zagni I, et al. Hepato- cellular carcinoma in cirrhosis : incidence and risk factors [ J ]. Gastroenterology, 2004, 127 (5 Suppl 1 ): S35-S50.
  • 10Chang TT, Liaw YF, Wu SS, et al. Long-term eritecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B - J ]. Hepatology, 2010,52(3) : 886 -893.

共引文献14042

同被引文献26

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部